VGLS Stock - VG Life Sciences Inc.
Unlock GoAI Insights for VGLS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-259,461 | $-260,343 | $-23,760 | $-1,164,640 | $-1,186,720 |
| Net Income | $2.12M | $-2,530,247 | $2.12M | $-1,240,346 | $-1,455,150 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $0.00 | $-0.00 | $0.00 | $-0.00 | $-0.01 |
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd.
Visit WebsiteEarnings History & Surprises
VGLSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 5, 2025 | — | — | — | — |
Q4 2015 | Nov 19, 2015 | — | $-0.01 | — | — |
Q2 2015 | Jun 30, 2015 | — | $-0.03 | — | — |
Q1 2015 | Mar 31, 2015 | — | $-0.04 | — | — |
Q4 2014 | Dec 31, 2014 | — | $-0.03 | — | — |
Q3 2014 | Sep 30, 2014 | — | $-0.06 | — | — |
Q2 2014 | Jun 30, 2014 | — | $-0.09 | — | — |
Q1 2014 | Mar 31, 2014 | — | $-0.14 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.22 | — | — |
Q3 2013 | Sep 30, 2013 | — | $-0.18 | — | — |
Q2 2011 | Jun 9, 2011 | — | — | — | — |
Q1 2011 | Feb 15, 2011 | — | — | — | — |
Q3 2007 | Sep 30, 2007 | — | $-4.37 | — | — |
Q2 2007 | Jun 30, 2007 | — | $-4.73 | — | — |
Q1 2007 | Mar 31, 2007 | — | $0.44 | — | — |
Q4 2006 | Dec 31, 2006 | — | $-11.23 | — | — |
Q3 2006 | Sep 30, 2006 | — | $-3.95 | — | — |
Q2 2006 | Jun 30, 2006 | — | $-11.14 | — | — |
Q1 2006 | Mar 31, 2006 | — | $-48.37 | — | — |
Q4 2005 | Dec 31, 2005 | — | $-10.11 | — | — |
Latest News
Frequently Asked Questions about VGLS
What is VGLS's current stock price?
What is the analyst price target for VGLS?
What sector is VG Life Sciences Inc. in?
What is VGLS's market cap?
Does VGLS pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VGLS for comparison